Page last updated: 2024-09-03

reboxetine and Attention Deficit and Disruptive Behavioral Disorders

reboxetine has been researched along with Attention Deficit and Disruptive Behavioral Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bronstein, Y; Laor, N; Ratner, S; Toren, P; Weizman, A	1

Trials

1 trial(s) available for reboxetine and Attention Deficit and Disruptive Behavioral Disorders

Article	Year
Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Morpholines; Reboxetine	2005

Article

Year

Six-week open-label reboxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:5

Topics: Adolescent; Adrenergic Uptake Inhibitors; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Child; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Morpholines; Reboxetine

2005